ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

 

ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy
M

A Genome-scale CRISPR Knock-out Screen in Chronic Myeloid Leukemia Identifies Common Drug Resistance Mechanisms Implicating Apoptotic and Transcriptional Machineries

By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Matthieu Lewis
By ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy FEATURING Matthieu Lewis
0 views
January 2, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi
Scientific Session 5: Mechanisms of Resistance and New Targets
15:26
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

A Genome-scale CRISPR Knock-out Screen in Chronic Myeloid Leukemia I…

Feat. M. Lewis
13:48
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Single-molecule Sequencing Reveals Patterns of Pre-existing Drug Res…

Feat. J. Pritchard
12:49
ESH iCMLf 20th Annual John Goldman Conference on Chronic Myeloid Leukaemia: Biology and Therapy

Modulation of p53 with the MDM2 Antagonist Idasanutlin, in Combinati…

Feat. D. Vetrie